Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.09.2021 | Case report

Linagliptin

Bullous pemphigoid: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Fußnoten
1
Identifying patient details (sex) have been obtained through direct communication with the author.
 
Literatur
Zurück zum Zitat Kinyo A, et al. Clinical, laboratory and histological features of dipeptidyl peptidase-4 inhibitor related noninflammatory bullous pemphigoid. Journal of Clinical Medicine 10: No. 9, 28 Apr 2021. Available from: URL: http://doi.org/10.3390/jcm10091916 Kinyo A, et al. Clinical, laboratory and histological features of dipeptidyl peptidase-4 inhibitor related noninflammatory bullous pemphigoid. Journal of Clinical Medicine 10: No. 9, 28 Apr 2021. Available from: URL: http://​doi.​org/​10.​3390/​jcm10091916
Metadaten
Titel
Linagliptin
Bullous pemphigoid: 2 case reports
Publikationsdatum
01.09.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-02212-y

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Apixaban

Case report

Diphenhydramine

Case report

Ranibizumab

Case report

Tozinameran

Case report

Hydrocortisone